8.76
price down icon1.24%   -0.11
after-market Handel nachbörslich: 8.70 -0.06 -0.68%
loading

Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.90%
13.25
14.54 13.46 10.70 15.43
Cost Of Revenue
10.15%
1.594
1.774 1.944 1.262 1.561
Gross Profit
8.72%
11.66
12.77 11.52 9.436 13.86
Operating Expenses
0.06%
81.42
81.47 79.16 73.35 59.86
Benefits Costs and Expenses
6.41%
77.90
83.24 81.10 74.75 61.42
Costs And Expenses
0.28%
83.01
83.24 81.10 74.61 61.42
Operating Income/Loss
1.55%
-69.76
-68.70 -67.64 -63.92 -46.00
Nonoperating Income/Loss
809.17%
5.106
-0.72 -0.173 -0.136 9.505
Income/Loss From Continuing Operations Before Tax
5.89%
-64.65
-68.70 -67.81 -64.05 -46.00
Income/Loss From Continuing Operations After Tax
6.86%
-64.65
-69.42 -67.81 -64.05 -36.49
Net Income/Loss
6.86%
-64.65
-69.42 -67.81 -64.05 -36.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
93.54%
11.88
183.92 172.59 169.40 166.99
Diluted Average Shares
93.54%
11.88
183.92 172.59 169.40 166.99
Basic Earnings Per Share
28.95%
-0.27
-0.38 -0.39 -0.38 -0.22
Diluted Earnings Per Share
28.95%
-0.27
-0.38 -0.39 -0.38 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):